Polar Capital Holdings Plc 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 09:39 am Sale |
2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Polar Capital Holdings Plc | 3,169,239 3.600% |
-1,679,394 (-34.64%) |
Filing |
| 2023-02-14 4:02 pm Purchase |
2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Polar Capital Holdings Plc | 4,848,633 5.900% |
4,848,633 (New Position) |
Filing |